Status:
COMPLETED
Dialysis Clinical Outcomes Revisited (DCOR) Trial
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained ...
Eligibility Criteria
Inclusion Criteria:
- patients must be 18 years of age or older,
- on dialysis for more than 3 months,
- require phosphate binder therapy,
- have Medicare as their primary insurance.
Exclusion Criteria:
- dysphagia,
- swallowing disorders,
- severe gastrointestinal motility disorders,
- bowel obstruction.
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00324571
Start Date
March 1 2001
End Date
February 1 2006
Last Update
March 18 2015
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Gambro Healthcare-Gadsden
Gadsden, Alabama, United States
2
nTouch Research
Huntsville, Alabama, United States
3
Kidney Health Institute, LLC
Tucson, Arizona, United States
4
Gambro Healthcare
El Cerrito, California, United States